Cargando…
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
Vaccinia virus (VACV) oncolytic therapy has been successful in a number of tumor models. In this study our goal was to generate a double recombinant vaccinia virus (VV-GMCSF-Lact) with enhanced antitumor activity that expresses exogenous proteins: the antitumor protein lactaptin and human granulocyt...
Autores principales: | Kochneva, Galina, Sivolobova, Galina, Tkacheva, Anastasiya, Grazhdantseva, Antonina, Troitskaya, Olga, Nushtaeva, Anna, Tkachenko, Anastasiya, Kuligina, Elena, Richter, Vladimir, Koval, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342044/ https://www.ncbi.nlm.nih.gov/pubmed/27708236 http://dx.doi.org/10.18632/oncotarget.12367 |
Ejemplares similares
-
Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
por: Koval, Olga, et al.
Publicado: (2017) -
Features of the Antitumor Effect of Vaccinia Virus Lister Strain
por: Zonov, Evgeniy, et al.
Publicado: (2016) -
Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
por: Kochneva, Galina, et al.
Publicado: (2014) -
Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
por: Vasileva, Natalia, et al.
Publicado: (2021) -
Complete Genome Sequence of Vaccinia Virus Strain L-IVP
por: Shvalov, Alexander N., et al.
Publicado: (2016)